| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in MLYS over the last quarter tilts toward selling: insiders offloaded a net 60,776 shares worth roughly $1.6M. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 2 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), MLYS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.90M | $203.25M | - | |
| Dir | 5.46M | $140.31M | - | |
| CEO | 603.6K | $15.52M | - | |
| Dir | 588.2K | $15.13M | - | |
| Other | 135.0K | $3.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | Gold Alexander M61 | Director | Sale+OE | 34,675 | $45.45 | $1,576,094.67 | -83.3% | -32.8% | - | |
| Nov 11, 2025 | Congleton Jon46 | Chief Executive Officer | Sell | 200,000 | $45.44 | $9,088,498.87 | -4.3% | -32.6% | - | |
| Nov 11, 2025 | Levy Adam Scott | CFO And Secretary | Sale+OE | 119,524 | $44.88 | $5,363,715.88 | -12.1% | -32.6% | - | |
| Oct 15, 2025 | Rodman David Malcom54 | Chief Medical Officer | Sell | 10,369 | $43.01 | $445,982.10 | -12.7% | -24.0% | - | |
| Oct 13, 2025 | Levy Adam Scott | CFO And Secretary | Sell | 10,758 | $42.01 | $451,983.56 | -4.3% | -23.4% | - | |
| Oct 13, 2025 | Congleton Jon46 | Chief Executive Officer | Sell | 15,100 | $42.67 | $644,326.87 | -0.9% | -23.4% | - | |
| Sep 15, 2025 | Rodman David Malcom54 | Chief Medical Officer | Sell | 11,367 | $36.00 | $409,265.98 | -6.4% | -0.5% | - | |
| Sep 4, 2025 | Ra Capital Management, L.P.52 | Director | Buy | 1,176,470 | $25.50 | $29,999,985.00 | +27.5% | +18.4% | - | |
| Sep 4, 2025 | Akkaraju Srinivas81 | Director | Buy | 588,235 | $25.50 | $14,999,992.50 | New | +18.4% | - | |
| Aug 13, 2025 | Rodman David Malcom54 | Chief Medical Officer | Sale+OE | 11,365 | $12.93 | $146,986.95 | -10.9% | +247.4% | - |